Skip to main content

Table 4 Risk factors for the occurrence of MAS

From: Total metabolic lesion volume of lymph nodes measured by 18F-FDG PET/CT: a new predictor of macrophage activation syndrome in adult-onset Still’s disease

 

Univariate analysis

Multivariate analysis

p

OR

95% CI

p

OR

95% CI

Age

0.138

0.955

0.898–1.015

    

Sex

0.784

1.366

0.147–12.677

    

LDH

0.009

1.005

1.001–1.008

    

PLT

0.035

0.992

0.984–0.999

    

IL-2R

0.002

1.002

1.001–1.003

0.002

1.003

1.001–1.007

SUVmax of the spleen > 3.55

0.004

19.170

2.182–2528.558

   

TLGtotal of LNs > 248,040

0.013

15.000

1.752–128.391

    

MLVtotal of LNs > 62.2

0.002

62.000

4.529–848.704

0.042

27.375

1.117–123,080.200

  1. Both TLGtotal and MLVtotal of LNs were calculated from the patients with hypermetabolic lymph nodes (n = 38). All laboratory variables were included in logistic regression, and only the results with p < 0.1 were listed here
  2. LDH lactate dehydrogenase, PLT platelet, IL-2R interleukin-2 receptor, SUV standardized uptake value, LN lymph node, TLG total lesion glycolysis, MLV metabolic lesion volume, MAS macrophage activation syndrome
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us